+91 9650760803 
Published: July 10, 2020 | Updated: July 20, 2026
Key Takeaways
- 01 Proven aim of therapy:
The treatment uses stem cells (often mesenchymal stem cells) to stimulate blood-vessel growth, enhance circulation, and promote tissue healing in limbs affected by CLI. - 02 Target patients are severe cases:
Designed for patients with CLI who face high risk of ulceration, gangrene, or amputation, especially when standard revascularisation is not viable. - 03 Evidence remains limited in scale:
Studies report improved perfusion, reduced amputation rates, and pain relief, but large-scale randomised trials and long-term data are still lacking. - 04 Treatment protocols and outcomes vary:
Results depend on stem cell source, delivery method (intramuscular vs intra-arterial), patient condition (diabetes, smoking), and follow-up care. - 05 Patients must weigh risk and cost:
The therapy is still experimental, involves substantial cost, and should be used alongside conventional medical management.
Overview
Critical Limb Ischemia (CLI) is the most advanced and severe stage of Peripheral Artery Disease (PAD). It develops when arteries supplying blood to the legs and feet become so narrowed or blocked by plaque that the tissue no longer receives enough oxygen and nutrients to remain healthy. Left untreated, this shortage of blood supply can progress from persistent pain to non-healing wounds, skin ulcers, and eventually gangrene, making CLI one of the leading causes of lower-limb amputation worldwide.
Unlike milder forms of PAD, which may cause discomfort only during activity (a pattern known as intermittent claudication), CLI is characterized by pain that persists even at rest, along with visible tissue changes. It is a medical emergency in the sense that timely intervention — whether through revascularization, medication, or regenerative approaches — can be the difference between saving a limb and losing it.
Types of Critical Limb Ischemia
- Acute CLI — a sudden blockage, typically caused by a blood clot, resulting in rapid-onset severe pain, tissue death, and a fast-moving risk of gangrene. This requires urgent medical attention.
- Chronic CLI — a gradual process in which atherosclerotic plaque builds up over years, slowly narrowing the arteries until blood flow becomes critically insufficient.
CLI shares close clinical overlap with several other vascular and organ-specific conditions Viezec treats, including Buerger’s Disease (a related inflammatory vascular condition affecting smaller arteries, often in smokers) and Cardiovascular Disease, since atherosclerosis affecting one vascular bed often reflects disease elsewhere in the circulatory system. Patients with long-standing diabetes are also disproportionately affected, as elevated blood sugar accelerates vascular damage and increases the risk of diabetic foot ulcers developing alongside CLI.
Prevention
While not all cases of CLI are preventable, several modifiable risk factors can meaningfully lower risk:
- Maintaining a healthy, active lifestyle with regular exercise
- Quitting smoking — one of the single largest risk factors for arterial disease
- Managing cholesterol and blood pressure within healthy ranges
- Controlling diabetes and blood sugar levels closely
Because CLI is a serious, progressive condition, patients experiencing warning signs should seek early evaluation. Those exploring regenerative options can review our Treatment section below, or read more about the broader class of conditions under Organ Specific Disorders.
Causes
CLI develops when the underlying process of atherosclerosis — the buildup of fatty plaque inside artery walls — progresses to the point where blood flow to the limbs is severely compromised. Several factors drive this process:
Atherosclerosis
Plaque made up of cholesterol, fat, and other substances gradually hardens and narrows the arteries. As the arterial channel shrinks, less oxygen-rich blood reaches the muscles and skin of the legs and feet.
Diabetes
Chronically elevated blood sugar damages both blood vessels and the nerves that regulate them, accelerating arterial narrowing and impairing the body’s ability to compensate through collateral circulation. This is why CLI and diabetic complications frequently occur together.
Peripheral Artery Disease (PAD)
CLI is, by definition, the end stage of untreated or progressive PAD. As arteries in the legs become increasingly narrowed, blood flow eventually drops below the threshold needed to keep tissue alive.
Other Contributing Factors
- Smoking, which damages the arterial lining and accelerates plaque formation
- High blood pressure and high cholesterol
- Obesity and sedentary lifestyle
- Chronic kidney disease, which is often linked with vascular damage — see Kidney Disorder Treatment
Reducing Risk
Patients can lower their risk of progression by controlling blood sugar, quitting smoking, staying physically active, and maintaining a balanced diet. If risk factors such as diabetes or existing PAD are present, regular vascular check-ups are strongly advised. Learn more about how CLI relates to earlier-stage arterial disease in our article on Peripheral Arterial Disease Leading to CLI.
Symptoms
Recognizing CLI symptoms early can be the deciding factor in preventing limb loss. Common warning signs include:
- Persistent pain in the foot or leg, including pain that occurs at rest, not just during activity
- Numbness or tingling in the affected limb
- Weakness in the leg or foot
- Sores or ulcers on the skin that do not heal, sometimes resembling diabetic foot ulcers in appearance
- Gangrene (visible tissue death), typically affecting the toes or foot
- Loss of hair on the lower leg or foot
- Skin that appears pale, shiny, or cool to the touch
- A weak or absent pulse in the foot or ankle
Because these symptoms often develop gradually in chronic cases, many patients delay seeking care until the condition has advanced significantly. If you notice any combination of these signs — particularly rest pain or non-healing wounds — prompt medical evaluation is essential. Early diagnosis allows for a wider range of treatment options, including regenerative approaches, before tissue damage becomes irreversible.
Diagnosis
Diagnosing CLI involves a combination of clinical evaluation and imaging to confirm the extent of arterial blockage.
Medical History and Physical Examination
The physician reviews the patient’s symptoms and risk factors — including diabetes, smoking history, and prior vascular disease — before examining the affected limb for signs such as weak pulses, skin changes, or wounds.
Ankle-Brachial Index (ABI)
This simple, non-invasive test compares blood pressure readings at the ankle to those at the arm. A significantly lower ankle reading indicates narrowed or blocked arteries in the leg.
Imaging Studies
Depending on findings, further imaging may be recommended:
- Doppler ultrasound — visualizes blood flow and identifies blockages
- CT angiography — provides detailed cross-sectional images of the arteries
- Magnetic resonance angiography (MRA) — maps blood vessels without radiation exposure
After Diagnosis
Once CLI is confirmed and its severity graded, the care team discusses treatment options, which may include lifestyle changes, medication, surgical revascularization, or — for eligible patients, particularly those who are not good candidates for conventional surgery — an evaluation for regenerative stem cell therapy.
Stem Cell Therapy for Critical Limb Ischemia
CLI is one of the more advanced applications of regenerative medicine in vascular disease, largely because conventional surgical revascularization is not always possible — some patients have blockages too diffuse or too distal to bypass or stent. For these “no-option” patients in particular, mesenchymal stem cells (MSCs) are being studied for their potential to stimulate angiogenesis — the formation of new blood vessels — as a way to restore circulation to oxygen-starved tissue.
How the Treatment Process Works
- Clinical Evaluation — A comprehensive vascular and medical assessment (see Diagnosis) determines disease severity and whether a patient may be a suitable candidate.
- Stem Cell Sourcing — Cells are commonly harvested from the patient’s own bone marrow (autologous), though peripheral blood or adipose (fat) tissue sources may also be used depending on the protocol.
- Laboratory Processing — Collected cells are processed under controlled laboratory conditions to isolate and prepare a concentrated, viable stem cell population, with quality verified through a Certificate of Analysis.
- Implantation — Processed cells are delivered to the affected limb using the method best suited to the patient’s condition (see Implantation).
- Monitoring and Follow-Up — Patients are monitored over subsequent weeks and months to assess changes in circulation, pain, and wound healing.
Why Patients Consider This Approach
Traditional treatment for CLI has historically centered on revascularization surgery or, in advanced cases, amputation. Regenerative approaches are being explored as a way to potentially:
- Support new blood vessel growth to improve tissue perfusion
- Aid healing of chronic non-healing wounds and ulcers
- Reduce inflammation contributing to pain and tissue damage
- Offer an option for patients who are not candidates for surgical revascularization
India has become a significant hub for this type of regenerative research, offering access to advanced laboratories and experienced specialists at a considerably lower cost than in many Western countries — without compromising on safety protocols. To understand the underlying science in more depth, visit our page on Physiological Mechanism of Stem Cell Therapy, or explore how this approach compares with related vascular conditions like Buerger’s Disease.
Implantation
The delivery method for stem cells in CLI treatment is selected based on the location and severity of arterial blockage, as well as the patient’s overall vascular condition. Commonly used routes include:
- Intra-arterial delivery — cells are infused directly through the artery supplying the affected limb, allowing more targeted delivery to ischemic tissue
- Intramuscular injection — cells are injected directly into the muscle of the affected limb, a widely used approach in CLI protocols
- Intravenous (IV) administration — allows systemic circulation of stem cells
- Intrathecal administration — used in select cases involving nerve-related complications
- Subcutaneous injection — delivered beneath the skin
- Liberation angioplasty — used in specific vascular presentations
- Surgical administration — reserved for more complex cases
The chosen combination is intended to maximize the cells’ potential reach to ischemic tissue while minimizing procedural risk. For a full technical breakdown of these methods, visit our dedicated page on Stem Cell Delivery Methods.
Frequently Asked Questions
What is stem cell treatment for critical limb ischemia?
Stem cell treatment involves using specialized stem cells to promote the growth of new blood vessels, improve blood flow, and support tissue repair in patients with critical limb ischemia (CLI).
Who is eligible for stem cell therapy for CLI?
Patients with severe peripheral artery disease, poor circulation in the legs, or non-healing ulcers who are not candidates for conventional surgery may benefit from stem cell therapy, subject to specialist evaluation.
How is stem cell therapy for CLI administered?
Stem cells are typically injected directly into the affected limb muscles or delivered intravenously under controlled clinical settings to promote angiogenesis and tissue repair.
Is stem cell therapy safe for patients with CLI?
When performed in certified clinics by experienced medical teams, stem cell therapy is generally safe. Minor side effects may include temporary pain, swelling, or mild fever at the injection site.
How long does it take to see improvements after treatment?
Improvements such as reduced pain, enhanced blood flow, and wound healing may appear gradually over weeks to months, depending on disease severity and individual response.
How many sessions are typically required?
The number of sessions varies by patient condition and treatment goals. Most patients undergo 1–3 sessions with follow-up assessments to monitor progress and vascular regeneration.
Can stem cell therapy replace surgical interventions for CLI?
Stem cell therapy is generally considered complementary to conventional treatments. In some cases where surgery is not possible, it may serve as a valuable alternative to improve limb perfusion and prevent amputations.
How can I schedule a consultation for stem cell therapy?
You can schedule a consultation by contacting our clinic via phone, email, or through the appointment form on our website. Our specialists will evaluate eligibility and provide a personalized treatment plan.
For more questions, visit our FAQs page or request an evaluation with our expert team.
How Much Does Stem Cell Therapy Cost for Critical Limb Ischemia?
The cost of stem cell therapy for Critical Limb Ischemia (CLI) depends on the patient’s condition severity, level of arterial blockage, extent of tissue damage, type of stem cells used, number of sessions required, and the expertise of the medical center. Costs also vary based on the country and healthcare infrastructure. Below is a general overview to understand how prices differ globally.
Cost Comparison: Select Countries
The following table provides estimated cost ranges reported by clinics and international patients for a complete stem cell therapy program for CLI, including medical assessment, stem cell processing, administration, and post-treatment follow-up.
| Country | Average Cost (in USD) | Average Cost (in INR) |
|---|---|---|
| United States 🇺🇸 | $18,000 – $32,000 | ₹14,90,000 – ₹26,50,000 |
| United Kingdom 🇬🇧 | $14,000 – $24,000 | ₹11,60,000 – ₹19,80,000 |
| Germany 🇩🇪 | $16,000 – $27,000 | ₹13,30,000 – ₹22,30,000 |
| Singapore 🇸🇬 | $12,000 – $20,000 | ₹9,90,000 – ₹16,50,000 |
While treatment in the USA, UK, and other developed nations offers advanced medical technologies, it is often associated with higher healthcare costs. In contrast, India offers high-quality regenerative treatment for CLI at a fraction of the cost, without compromising on medical standards, safety, or patient care.
India’s lower cost advantage arises from affordable healthcare infrastructure, competitive pricing, and favorable exchange rates — not from reduced quality. Many Indian hospitals follow internationally approved stem cell protocols, maintain advanced laboratories, and employ globally trained specialists to ensure optimal recovery and improved limb perfusion.
Why Choose Viezec?
Viezec partners with accredited regenerative medicine centers that specialize in stem cell therapy for Critical Limb Ischemia. Our team ensures ethical medical practices, transparent pricing, and complete patient support throughout your treatment journey.
Get a Personalized Cost Estimate
Every CLI case is unique. Connect with our medical experts for a personalized quotation and a treatment plan tailored to your specific health condition and vascular profile.
Improvements
Patients undergoing stem cell therapy for CLI have reported a range of improvements associated with better circulation and reduced tissue damage, including:
- Improved blood supply to the extremities
- Reduced pain, including rest pain
- Reduction in skin ulcers and sores
- Faster wound healing
- Reduced fatigue and lower risk of further infection
These outcomes vary from patient to patient depending on disease severity, overall health, and how advanced the arterial blockage was at the time of treatment. For related complications sometimes seen alongside CLI, see our page on Diabetic Foot Ulcers.
Mechanism
Stem cell therapy for CLI centers on the biological process of angiogenesis — the formation of new blood vessels — which researchers are studying as a way to restore blood supply to tissue that has been deprived of oxygen and nutrients due to arterial blockage. Key mechanisms under investigation include:
- Angiogenesis support — MSCs and related cell types are studied for their potential to stimulate the growth of new microvasculature around blocked or narrowed arteries, creating alternative pathways for blood flow.
- Paracrine signaling — stem cells release growth factors and signaling molecules that may support tissue repair and encourage surrounding cells to participate in the healing process.
- Anti-inflammatory effects — by modulating local inflammation, stem cells may help reduce the tissue damage that drives pain and ulceration in CLI.
- Tissue regeneration support — cells may aid in the repair of damaged skin and muscle tissue affected by chronic poor circulation.
This mechanism is closely related to the regenerative processes studied in other vascular conditions, including Buerger’s Disease and Cardiovascular Disease. For a deeper look at the underlying biology, visit Physiological Mechanism of Stem Cell Therapy.
Our Promise
At Viezec, we work with a network of accredited regenerative medicine centers experienced in treating vascular conditions such as CLI. Our commitment to patients includes:
- Access to highly qualified, experienced medical specialists
- Strict adherence to patient safety standards throughout every procedure
- A compassionate, patient-first environment designed to make each person feel supported
- Transparent guidance and flexible payment options so cost is never a barrier to informed decision-making
- Continuous support from initial consultation through post-treatment follow-up
To understand more about why international patients choose India for regenerative care, visit Why Stem Cell Therapy in India.
Treatment Results
Stem cell treatment for Critical Limb Ischemia is studied as a way to reduce disease-related risks — including tissue death and amputation — associated with severely restricted blood flow. Patients treated for CLI have reported improvements such as:
- Reduced pain
- Fewer sores and skin ulcers
- Less fatigue
- Improved blood supply to the limbs
These therapies aim to improve quality of life by minimizing symptoms and complications associated with advanced vascular disease. Outcomes are individual and cannot be guaranteed. For patient video accounts, see Patient Videos below or visit our YouTube channel.
Testimonials
Vikram S. – Jaipur, India – February 2020 – ⭐⭐⭐⭐☆
“I was facing the risk of amputation due to poor blood flow. After Viezec’s stem cell therapy, circulation improved, and I can walk without severe pain.”
Sarah J. – Birmingham, UK – July 2020 – ⭐⭐⭐⭐⭐
“Critical limb ischemia left me with non-healing wounds. Post-treatment at Viezec, the wounds healed faster, and pain reduced.”
Mohammed A. – Doha, Qatar – November 2020 – ⭐⭐⭐⭐☆
“My father had severe leg pain from CLI. After stem cell therapy, his walking distance improved, and swelling reduced noticeably.”
Ana P. – Lisbon, Portugal – March 2021 – ⭐⭐⭐⭐⭐
“I had constant numbness and ulcers on my feet. Thanks to Viezec’s therapy, my circulation improved, and the ulcers healed gradually.”
Peter K. – Berlin, Germany – September 2021 – ⭐⭐⭐⭐☆
“CLI had made it impossible to walk short distances. After treatment at Viezec, the blood flow improved, and the pain reduced.”
Carolina M. – São Paulo, Brazil – February 2022 – ⭐⭐⭐⭐⭐
“Doctors suggested possible amputation. Viezec’s stem cell therapy saved my leg, and I feel healthier and more independent now.”
Hassan R. – Muscat, Oman – August 2022 – ⭐⭐⭐⭐☆
“My brother struggled with ischemic pain day and night. After Viezec’s therapy, his leg wounds healed, and pain became manageable.”
Elena S. – Warsaw, Poland – April 2023 – ⭐⭐⭐⭐⭐
“I had critical limb ischemia with poor healing. Stem cell therapy at Viezec restored blood supply, and my mobility improved.”
George D. – Sydney, Australia – October 2023 – ⭐⭐⭐⭐☆
“CLI made walking a struggle. After treatment at Viezec, my circulation improved, and my quality of life feels restored.”
Fatou N. – Dakar, Senegal – May 2025 – ⭐⭐⭐⭐⭐
“I was afraid of losing my leg. Thanks to Viezec’s stem cell therapy, my wounds healed, pain reduced, and amputation was avoided.”
Treatment Disclaimer
Ahead of undergoing this procedure, patients should understand that stem cell therapy remains an experimental approach that may not produce the desired effect in every case. Depending on individual evaluation, treatment may be declined, or the recommended protocol adjusted based on the patient’s health condition.
Our goal is to provide access to the safest, most current techniques available, in line with globally recognized standards. As with any medical treatment, no outcome can be guaranteed — individual biology varies, and results differ from patient to patient even with a similar diagnosis. No embryonic or fetal cells are used in any of our treatment protocols.
Scientific References
The following peer-reviewed publications and clinical studies support current research on stem cell therapy for Critical Limb Ischemia.
Conclusion
Stem cell therapy for Critical Limb Ischemia represents an evolving approach to restoring blood flow, supporting tissue repair, and potentially reducing the need for amputation in patients who may have limited conventional treatment options. At Viezec, we combine access to advanced regenerative medicine centers with ethical guidance and complete patient support, helping patients make informed decisions about their vascular health. To explore whether this approach may be relevant to your condition, connect with our specialists via our contact page.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
Ask Your Query
We Also Offer Treatments For
Our Testimonials
Related Videos
Recent Blog Posts
4.8 average based on 654 reviews.
